Camurus AB Net Income
| CAMRF Stock | USD 55.00 3.00 5.17% |
As of the 2nd of March, Camurus AB shows the Risk Adjusted Performance of (0.05), mean deviation of 0.8121, and Standard Deviation of 2.74. Camurus AB technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for twelve technical drivers for Camurus AB, which can be compared to its peers. Please confirm Camurus AB standard deviation and maximum drawdown to decide if Camurus AB is priced correctly, providing market reflects its regular price of 55.0 per share. Given that Camurus AB has total risk alpha of (0.49), we suggest you to validate Camurus AB's prevailing market performance to make sure the company can sustain itself at a future point.
Camurus AB's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Camurus AB's valuation are provided below:Camurus AB does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Camurus |
Camurus AB 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Camurus AB's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Camurus AB.
| 12/02/2025 |
| 03/02/2026 |
If you would invest 0.00 in Camurus AB on December 2, 2025 and sell it all today you would earn a total of 0.00 from holding Camurus AB or generate 0.0% return on investment in Camurus AB over 90 days. Camurus AB is related to or competes with Laboratorios Farmaceuticos, Genscript Biotech, ALK-Abelló A/S, Ambu A/S, InnoCare Pharma, Shanghai Junshi, and Telix Pharmaceuticals. Camurus AB , a pharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe... More
Camurus AB Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Camurus AB's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Camurus AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 27.05 | |||
| Value At Risk | (0.04) |
Camurus AB Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Camurus AB's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Camurus AB's standard deviation. In reality, there are many statistical measures that can use Camurus AB historical prices to predict the future Camurus AB's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.28) | |||
| Total Risk Alpha | (0.49) | |||
| Treynor Ratio | (0.21) |
Camurus AB March 2, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.20) | |||
| Mean Deviation | 0.8121 | |||
| Coefficient Of Variation | (1,410) | |||
| Standard Deviation | 2.74 | |||
| Variance | 7.5 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.28) | |||
| Total Risk Alpha | (0.49) | |||
| Treynor Ratio | (0.21) | |||
| Maximum Drawdown | 27.05 | |||
| Value At Risk | (0.04) | |||
| Skewness | (4.20) | |||
| Kurtosis | 33.05 |
Camurus AB Backtested Returns
Camurus AB secures Sharpe Ratio (or Efficiency) of -0.0732, which signifies that the company had a -0.0732 % return per unit of risk over the last 3 months. Camurus AB exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Camurus AB's Mean Deviation of 0.8121, risk adjusted performance of (0.05), and Standard Deviation of 2.74 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.96, which signifies possible diversification benefits within a given portfolio. Camurus AB returns are very sensitive to returns on the market. As the market goes up or down, Camurus AB is expected to follow. At this point, Camurus AB has a negative expected return of -0.21%. Please make sure to confirm Camurus AB's total risk alpha, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Camurus AB performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.71 |
Almost perfect reverse predictability
Camurus AB has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Camurus AB time series from 2nd of December 2025 to 16th of January 2026 and 16th of January 2026 to 2nd of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Camurus AB price movement. The serial correlation of -0.71 indicates that around 71.0% of current Camurus AB price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.71 | |
| Spearman Rank Test | -0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 43.95 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Camurus AB reported net income of (23.45 Million). This is much lower than that of the sector and significantly lower than that of the Net Income industry. The net income for all United States stocks is notably higher than that of the company.
Camurus Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Camurus AB's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Camurus AB could also be used in its relative valuation, which is a method of valuing Camurus AB by comparing valuation metrics of similar companies.Camurus AB is currently under evaluation in net income category among its peers.
Camurus Fundamentals
| Return On Equity | -1.49 | |||
| Return On Asset | -0.83 | |||
| Profit Margin | (1.62) % | |||
| Current Valuation | 1.2 B | |||
| Shares Outstanding | 38.38 M | |||
| Shares Owned By Insiders | 52.99 % | |||
| Shares Owned By Institutions | 21.99 % | |||
| Price To Book | 11.42 X | |||
| Price To Sales | 80.89 X | |||
| Revenue | 4.5 M | |||
| Gross Profit | 515.22 M | |||
| EBITDA | (29 M) | |||
| Net Income | (23.45 M) | |||
| Cash And Equivalents | 22.42 M | |||
| Cash Per Share | 0.58 X | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 3.29 X | |||
| Book Value Per Share | 1.12 X | |||
| Cash Flow From Operations | (24.54 M) | |||
| Earnings Per Share | (0.63) X | |||
| Number Of Employees | 157 | |||
| Beta | 1.08 | |||
| Market Capitalization | 853.56 M |
About Camurus AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Camurus AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Camurus AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Camurus AB based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Camurus OTC Stock
Camurus AB financial ratios help investors to determine whether Camurus OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Camurus with respect to the benefits of owning Camurus AB security.